GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » EBIT

Nanjing Vishee Medical Technology Co (SHSE:688580) EBIT : ¥126.8 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co EBIT?

Nanjing Vishee Medical Technology Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was ¥30.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥126.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nanjing Vishee Medical Technology Co's annualized ROC % for the quarter that ended in Jun. 2024 was 15.21%. Nanjing Vishee Medical Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 34.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nanjing Vishee Medical Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 13.03%.


Nanjing Vishee Medical Technology Co EBIT Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co EBIT Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.69 166.49 197.57 106.17 151.33

Nanjing Vishee Medical Technology Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.93 35.07 38.14 23.05 30.54

Competitive Comparison of Nanjing Vishee Medical Technology Co's EBIT

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Vishee Medical Technology Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's EV-to-EBIT falls into.



Nanjing Vishee Medical Technology Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥126.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Vishee Medical Technology Co  (SHSE:688580) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nanjing Vishee Medical Technology Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=97.804 * ( 1 - 7.79% )/( (578.484 + 607.119)/ 2 )
=90.1850684/592.8015
=15.21 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1796.524 - 111.836 - ( 1114.688 - max(0, 116.028 - 1222.232+1114.688))
=578.484

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1743.949 - 133.706 - ( 1027.847 - max(0, 138.279 - 1141.403+1027.847))
=607.119

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Nanjing Vishee Medical Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=122.176/( ( (336.433 + max(-14.59, 0)) + (365.535 + max(-30.076, 0)) )/ 2 )
=122.176/( ( 336.433 + 365.535 )/ 2 )
=122.176/350.984
=34.81 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(36.73 + 41.274 + 23.434) - (111.836 + 0 + 4.192)
=-14.59

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.761 + 44.512 + 23.93) - (133.706 + 0 + 4.573)
=-30.076

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nanjing Vishee Medical Technology Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=126.801/973.323
=13.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Vishee Medical Technology Co EBIT Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Executives
Huang He Senior management, core technical personnel
Chou Kai Senior management, core technical personnel
Zhong Yi Qun senior management
Chen Li Li Directors, senior managers
Zhang Hui senior management
Gao Fei Core technical personnel
Lian Qing Ming Director

Nanjing Vishee Medical Technology Co Headlines

No Headlines